312 related articles for article (PubMed ID: 26455359)
1. Effect of socioeconomic status on hepatocellular carcinoma incidence and stage at diagnosis, a population-based cohort study.
Anyiwe K; Qiao Y; De P; Yoshida EM; Earle CC; Thein HH
Liver Int; 2016 Jun; 36(6):902-10. PubMed ID: 26455359
[TBL] [Abstract][Full Text] [Related]
2. High incidence of hepatocellular carcinoma in ESRD patients: caused by high hepatitis rate or 'uremia'? a population-based study.
Hwang JC; Weng SF; Weng RH
Jpn J Clin Oncol; 2012 Sep; 42(9):780-6. PubMed ID: 22782961
[TBL] [Abstract][Full Text] [Related]
3. Trends in incidence of hepatocellular carcinoma after diagnosis of hepatitis B or C infection: a population-based cohort study, 1992-2007.
Thein HH; Walter SR; Gidding HF; Amin J; Law MG; George J; Dore GJ
J Viral Hepat; 2011 Jul; 18(7):e232-41. PubMed ID: 21692938
[TBL] [Abstract][Full Text] [Related]
4. Influence of socioeconomic status on survival of hepatocellular carcinoma in the Ontario population; a population-based study, 1990-2009.
Jembere N; Campitelli MA; Sherman M; Feld JJ; Lou W; Peacock S; Yoshida E; Krahn MD; Earle C; Thein HH
PLoS One; 2012; 7(7):e40917. PubMed ID: 22808283
[TBL] [Abstract][Full Text] [Related]
5. Rising incidence of hepatitis B-related hepatocellular carcinoma in South Australia: 1996-2010.
Chinnaratha MA; Graham C; Fraser RJ; Woodman RJ; Wigg AJ
Intern Med J; 2016 Aug; 46(8):902-8. PubMed ID: 27130077
[TBL] [Abstract][Full Text] [Related]
6. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
[TBL] [Abstract][Full Text] [Related]
7. Effects of socioeconomic status on esophageal adenocarcinoma stage at diagnosis, receipt of treatment, and survival: A population-based cohort study.
Thein HH; Anyiwe K; Jembere N; Yu B; De P; Earle CC
PLoS One; 2017; 12(10):e0186350. PubMed ID: 29020052
[TBL] [Abstract][Full Text] [Related]
8. Novel population-based study finding higher than reported hepatocellular carcinoma incidence suggests an updated approach is needed.
Hong TP; Gow P; Fink M; Dev A; Roberts S; Nicoll A; Lubel J; Kronborg I; Arachchi N; Ryan M; Kemp W; Knight V; Farrugia H; Thursfield V; Desmond P; Thompson AJ; Bell S
Hepatology; 2016 Apr; 63(4):1205-12. PubMed ID: 26435297
[TBL] [Abstract][Full Text] [Related]
9. Incidence and risk factors for hepatocellular carcinoma after solid organ transplantation.
Hoffmann CJ; Subramanian AK; Cameron AM; Engels EA
Transplantation; 2008 Sep; 86(6):784-90. PubMed ID: 18813102
[TBL] [Abstract][Full Text] [Related]
10. Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study.
Kim G; Jang SY; Han E; Lee YH; Park SY; Nam CM; Kang ES
Int J Cancer; 2017 Feb; 140(4):798-806. PubMed ID: 27861855
[TBL] [Abstract][Full Text] [Related]
11. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study.
El-Serag HB; Davila JA
Hepatology; 2004 Mar; 39(3):798-803. PubMed ID: 14999699
[TBL] [Abstract][Full Text] [Related]
12. Combined effect of socioeconomic status, viral hepatitis, and lifestyles on hepatocelluar carcinoma risk in Korea.
Yun EH; Lim MK; Oh JK; Park JH; Shin A; Sung J; Park EC
Br J Cancer; 2010 Aug; 103(5):741-6. PubMed ID: 20648009
[TBL] [Abstract][Full Text] [Related]
13. Fine Particle Pollution, Alanine Transaminase, and Liver Cancer: A Taiwanese Prospective Cohort Study (REVEAL-HBV).
Pan WC; Wu CD; Chen MJ; Huang YT; Chen CJ; Su HJ; Yang HI
J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26561636
[TBL] [Abstract][Full Text] [Related]
14. Improved Survival in Patients with Viral Hepatitis-Induced Hepatocellular Carcinoma Undergoing Recommended Abdominal Ultrasound Surveillance in Ontario: A Population-Based Retrospective Cohort Study.
Thein HH; Campitelli MA; Yeung LT; Zaheen A; Yoshida EM; Earle CC
PLoS One; 2015; 10(9):e0138907. PubMed ID: 26398404
[TBL] [Abstract][Full Text] [Related]
15. Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease.
Kanwal F; Kramer JR; Mapakshi S; Natarajan Y; Chayanupatkul M; Richardson PA; Li L; Desiderio R; Thrift AP; Asch SM; Chu J; El-Serag HB
Gastroenterology; 2018 Dec; 155(6):1828-1837.e2. PubMed ID: 30144434
[TBL] [Abstract][Full Text] [Related]
16. Ambient ultraviolet radiation exposure and hepatocellular carcinoma incidence in the United States.
VoPham T; Bertrand KA; Yuan JM; Tamimi RM; Hart JE; Laden F
Environ Health; 2017 Aug; 16(1):89. PubMed ID: 28821245
[TBL] [Abstract][Full Text] [Related]
17. Time-trends in incidence and prognosis of hepatocellular carcinoma in Denmark: A nationwide register-based cohort study.
Jepsen P; Andersen MW; Villadsen GE; Ott P; Vilstrup H
Liver Int; 2017 Jun; 37(6):871-878. PubMed ID: 27943604
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for hepatocellular carcinoma in a cohort infected with hepatitis B or C.
Walter SR; Thein HH; Gidding HF; Amin J; Law MG; George J; Dore GJ
J Gastroenterol Hepatol; 2011 Dec; 26(12):1757-64. PubMed ID: 21615789
[TBL] [Abstract][Full Text] [Related]
19. Significant reduction in end-stage liver diseases burden through the national viral hepatitis therapy program in Taiwan.
Chiang CJ; Yang YW; Chen JD; You SL; Yang HI; Lee MH; Lai MS; Chen CJ
Hepatology; 2015 Apr; 61(4):1154-62. PubMed ID: 25476749
[TBL] [Abstract][Full Text] [Related]
20. Trends in epidemiology, treatment, and survival of hepatocellular carcinoma patients between 1998 and 2009: an analysis of 1066 cases of a German HCC Registry.
Weinmann A; Koch S; Niederle IM; Schulze-Bergkamen H; König J; Hoppe-Lotichius M; Hansen T; Pitton MB; Düber C; Otto G; Schuchmann M; Galle PR; Wörns MA
J Clin Gastroenterol; 2014 Mar; 48(3):279-89. PubMed ID: 24045276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
